On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its ...
The Associated Press on MSN5d
EU Commission fines Teva $500 million for trying to stop rival’s multiple sclerosis drugThe European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly ...
Teva Pharmaceuticals is being fined $503 million (€463 million) by the European Commission for delaying competition posed by ...
European Commission says company abused ‘dominant position’ to ‘artificially’ extend patent protection of MS medicine ...
The fine of €462.6 million ($503 million) is believed to be the largest imposed on a pharma company for breaking antitrust ...
Teva Fined Around $500 Million by EU Over MS Drug Competition Concerns ...
The European Commission (EC) has fined pharmaceutical company Teva €462.6 million for “systematically spread[ing] misleading ...
TEL AVIV, Israel, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals Industries Ltd. (NYSE: and TASE: TEVA) is responding to the European ... disagrees with the Commission’s legal theories ...
BRUSSELS -- The European Commission said Thursday it has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its ...
Teva Statement on European Commission Decision; Company to Appeal GlobeNewswire October 31, 2024 Teva Pharmaceuticals ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback